NPI: 1619397700 · GARDEN GROVE, CA 92843 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/16/2014
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/16/2014 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,441 | $1.34M |
| 2019 | 32,435 | $1.41M |
| 2020 | 46,850 | $1.69M |
| 2021 | 45,222 | $1.55M |
| 2022 | 34,995 | $1.62M |
| 2023 | 20,445 | $2.51M |
| 2024 | 5,888 | $1.36M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 83,289 | 6,187 | $9.56M |
| A4657 | Syringe, with or without needle, each | 3,181 | 2,606 | $1.16M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 2,137 | 1,168 | $220K |
| 0250 | 3,744 | 708 | $180K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 29,397 | 2,544 | $124K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 56,692 | 4,070 | $110K |
| J1756 | Injection, iron sucrose, 1 mg | 14,807 | 3,764 | $83K |
| 82728 | 1,572 | 1,407 | $29K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 191 | 179 | $5K |
| 90677 | 12 | 12 | $3K | |
| 90674 | 143 | 132 | $3K | |
| 90662 | 106 | 105 | $3K | |
| 83540 | 1,666 | 1,466 | $2K | |
| 83970 | 1,709 | 1,562 | $1K | |
| G0008 | Administration of influenza virus vaccine | 93 | 87 | $818.84 |
| 85041 | 2,474 | 2,189 | $744.62 | |
| 90661 | 19 | 19 | $600.57 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,098 | 777 | $554.46 |
| 83550 | 1,635 | 1,437 | $86.99 | |
| 85048 | 2,455 | 2,174 | $32.31 | |
| 82108 | 131 | 125 | $19.72 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 465 | 55 | $0.00 |
| 0301 | 89 | 31 | $0.00 | |
| 0821 | 66 | 56 | $0.00 | |
| 0305 | 88 | 41 | $0.00 | |
| 0270 | 56 | 43 | $0.00 | |
| 0636 | 674 | 54 | $0.00 | |
| 0634 | 1,239 | 68 | $0.00 | |
| 0302 | 48 | 26 | $0.00 |